AG
TMO icon

Ascent Group’s Thermo Fisher Scientific TMO Stock Holding History

Ascent Group’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.67M Buy
11,305
+84
+0.7% +$40.3K 0.17% 124
2026
Q1 		$5.52M Sell
11,221
-355
-3% -$193K 0.19% 114
2025
Q4 		$6.71M Buy
11,576
+613
+6% +$347K 0.23% 93
2025
Q3 		$5.32M Buy
10,963
+3,119
+40% +$1.45M 0.19% 114
2025
Q2 		$3.18M Sell
7,844
-1,007
-11% -$421K 0.12% 162
2025
Q1 		$4.4M Buy
8,851
+1,454
+20% +$787K 0.19% 117
2024
Q4 		$3.85M Sell
7,397
-699
-9% -$384K 0.29% 88
2024
Q3 		$5.01M Sell
8,096
-2,933
-27% -$1.74M 0.38% 57
2024
Q2 		$6.1M Buy
11,029
+561
+5% +$321K 0.5% 41
2024
Q1 		$6.08M Buy
10,468
+3,484
+50% +$1.96M 0.54% 33
2023
Q4 		$3.82M Buy
6,984
+24
+0.3% +$11.6K 0.36% 61
2023
Q3 		$3.09M Sell
6,960
-111
-2% -$59.1K 0.34% 69
2023
Q2 		$3.93M Sell
7,071
-779
-10% -$420K 0.43% 53
2023
Q1 		$4.52M Sell
7,850
-876
-10% -$494K 0.48% 41
2022
Q4 		$4.81M Buy
8,726
+530
+6% +$281K 0.57% 33
2022
Q3 		$4.21M Buy
8,196
+115
+1% +$64.4K 0.51% 43
2022
Q2 		$4.84M Buy
8,081
+431
+6% +$237K 0.58% 32
2022
Q1 		$4.52M Sell
7,650
-23
-0.3% -$13.2K 0.53% 42
2021
Q4 		$4.45M Buy
+7,673
New +$4.79M 0.57% 36

Other funds holding TMO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Ascent Group's TMO Position: Q2 2026 in Review

Ascent Group increased its Thermo Fisher Scientific (TMO) stake by 0.75% in Q2 2026, buying an estimated $40.3K and bringing the position to 11,305 shares worth $5.67M. The position accounts for 0.17% of the portfolio, ranked #124.

Ascent Group first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $6.71M in Q4 2025. 2,620 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Ascent Group held 11,305 shares of Thermo Fisher Scientific worth $5.67M as of Q2 2026.
  • Ascent Group bought 84 Thermo Fisher Scientific shares in Q2 2026, an estimated $40.3K.
  • Thermo Fisher Scientific made up 0.17% of Ascent Group's portfolio in Q2 2026, its #124 holding.
  • Ascent Group first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Ascent Group's Thermo Fisher Scientific position peaked at $6.71M in Q4 2025.
  • 2,620 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Ascent Group's 13F filing for Q2 2026, filed 3 Aug 2026.